Case Study: Takeda improves IBD patient monitoring with Olotila by Taiste

Takeda supports IBD patients for several years with Taiste

Takeda, a global pharmaceutical company, partnered with Taiste to enhance the Olotila application for patients with inflammatory bowel disease (IBD). The challenge was to redesign the app to increase its usability and make it easier for both patients and healthcare professionals to generate and read well-being reports.

Taiste redesigned the application using Google's Material Design for a familiar and effortless user experience, and rebuilt it with React and Cordova to create a single code base for both iOS and Android. The solution made it effortless for patients to track their condition and for doctors to use clear graphs for treatment planning. Studies showed that IBD patients who actively monitor their condition with digital apps achieve better treatment results.

Takeda